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EXERCISE-INDUCED MYOCARDIAL JSCHAEKIA IN MfN WITH ANGINA 
IS IMPROVED BY A NEW COMPOUND blITH ALPHA-2 ADRENOCEPTOR 
AGONIST ACTIVITY 
Fiobert A Wriqht, Tanya Kharkevitch, Mlchae: F Oliver, 
University of Edinburgh, Scotland 
UCB 22073 is an imidazole derivative with aqonlst 
activity at the alpha-2 adrenoceptor. We have evaluated 
this aqent in 6 men (mean age 57 years) with chroni, 
stable angina by serial exercise testing in a double- 
blind, randomised, placebo-controlled crossover study. 
Regular anti-angina1 medication was withdrawn for 72 hours 
before entry into the study. On 5 consecutive days, 
3 increasing intravenous doses of UCB 22073 were compared 
with placebo usinq a standard Bruce protocol on an 
automated treadmill. 
% Increase in time Dose lug/kg) 
compared to placebo 1 2 3 
Exercise Duration 15 23 =* 30 ** 
Onset nf Angina 39 48 * 60 * 
lmm ST Depression 36 76 * 103 *+I* 
* p < 0.05, eii p < 0.01, a** p ( 0.001 
The drug was well tolerated and there were no clinically 
significant side-effects. 
CONCLUSION 
UCB 22073 given intravenously In a dose of 2 uq/kq or 
3 uq/kq significantly increases total treadmill exercise 
duration, the time to onset of angina and time to lmm ST 
depression in patients with chronic stable anqlna. 
NC SIGNIFICANTLY ALTERS MYOCi%.RD”AL PET 
Karen S. Pieper, John M. Hoffman, R. 
tke University, Durham, HC 
Seventeen no al volunteers had cardiac PET imaging with 
FDG (F) and 3 (N) in the glucose loaded (GL) (50 gm 
glucose P.O.) and fasted (f) state (f > 12 hours) with 
simultaneous determination of serum glucose (Cl, insulin 
(I) and free fatty acid (FFA). Regions of interest were 
placed on the septal (S), anterior, anterolateral, 
rolateral walls of the myocardium (M) as well as in 
Iood pool (BP), and mean counts were det 
N in the GL and F state?. The ratio of 
etermined for F and W in the GL and F state. The 
P behaved homogeneously with respect to F and N 
distribution between the 4 walls. 
Results: Expressed as ratio af GL/f values 
3 G I FFA 
Mean 2.47 1.03 I .45 5.38 0.41 
2 S.D. 1.04 0.31 0.25 
P* <O.QOl =0.70 0s) CO.001 
*p value represents T-test of ratio f 1 
There was no correlation between G, I or FFA and either 
M/BP (F or N) in the GL or F state. 
Thus, CL increases /BP for F but not N. GL also 
increases G and I while Simultaneously decreasing FFA. 
The relatlonship between these variables remains 
speculative. 
Sung-Cheng uang, Heinrich R 
Schelben. UCLA edi& School, Los Angeles, CA 
lnlravenous dobutamine has been introduced as an 
alternative 10 exercise stress resting 10 evalua:e pa:ients 
with known or suspected coronary artery disese (CAD). To 
assess the effects of intravenous dobutamine on myocardial 
blood flow (MBF). we used dynamic positron emission 
tomography (PET) with Nitrogen-13 ammonia. This 
technique has been used previously with a 2 compartment 
marhematical model to quanlirate MBF at rest and with 
exercise. Eight healthy volunteers (mean age 24f4 yrs) 
were studied with Nitrogen-13 ammonia delivered at rest 
and during the intravenous infusion of 40 pg/kg/min of 
dobutamine. An average of 4 image planes per volunlecr 
were each divided into 16 equal sectors and MBF was 
determined for each sector. Rest and dobutamine glucose 
(91f8 vs 99f9 mg%) and lactate levels (7f2 vs 6f2 mgE) 
were similar, but free fatty acid levels increased from 
0.19fo.08 to O.67H.36 meq/l (pcO.05) with dobutamine. The 
rest rate-pressure product increa d 2.8-fold from 
6,88 lfl.826 10 18.546zt4.459 bpm/mm g (pcO.05) at peak 
dobutamine infusion. The MBF also increased 2%fold from 
0.82f0.22 lo 2.21f0.37 ml/min/g (~~0.05). We conclude lha( 
dobutamine induces a significant increase in rate-pressure 
product paralleled by a proporlional increase in MBF and, 
thus. should prove useful in Ihe detection of functionally 
significant CAD with PET. 
